FGP
Foyston, Gordon, & Payne Portfolio holdings
AUM
$439M
This Quarter Return
+9.6%
1 Year Return
+25.58%
3 Year Return
+78.33%
5 Year Return
+134.68%
10 Year Return
+224.6%
AUM
$415M
AUM Growth
+$415M
(+4.3%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
43.54%
Holding
60
New
2
Increased
8
Reduced
37
Closed
2
Top Buys
| 1 |
Henry Schein
HSIC
|
$5.43M |
| 2 |
Broadcom
AVGO
|
$5.34M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$2.36M |
| 4 |
Truist Financial
TFC
|
$1.89M |
| 5 |
UnitedHealth
UNH
|
$1.85M |
Top Sells
| 1 |
Humana
HUM
|
$5.83M |
| 2 |
Zebra Technologies
ZBRA
|
$4.22M |
| 3 |
Ulta Beauty
ULTA
|
$3.53M |
| 4 |
Keysight
KEYS
|
$3.11M |
| 5 |
PepsiCo
PEP
|
$2.99M |
Sector Composition
| 1 | Technology | 25.17% |
| 2 | Healthcare | 18.58% |
| 3 | Financials | 15.29% |
| 4 | Consumer Staples | 12.54% |
| 5 | Consumer Discretionary | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
A.O. Smith
AOS
$9.92B
| $6.68M | 1.61% |
74,725
-2,071
| -3% | -$185K |
|
27
Gentex
GNTX
$6.07B
| $5.9M | 1.42% |
163,419
-4,784
| -3% | -$173K |
|
28
SEI Investments
SEIC
$10.8B
| $5.85M | 1.41% |
81,311
-3,119
| -4% | -$224K |
|
29
Willis Towers Watson
WTW
$31.9B
| $5.77M | 1.39% |
20,970
| – | – |
|
30
Coca-Cola
KO
$297B
| $5.73M | 1.38% |
93,720
| – | – |
|
31
Otis Worldwide
OTIS
$33.6B
| $5.54M | 1.33% |
55,817
-945
| -2% | -$93.8K |
|
32
L3Harris
LHX
$51.1B
| $5.28M | 1.27% |
24,779
-437
| -2% | -$93.1K |
|
33
Aon
AON
$80.6B
| $5.04M | 1.21% |
15,110
-395
| -3% | -$132K |
|
|
34
Ulta Beauty
ULTA
$23.8B
| $4.97M | 1.2% |
9,496
-6,746
| -42% | -$3.53M |
|
35
CME Group
CME
$97.1B
| $4.83M | 1.16% |
22,416
+3,786
| +20% | +$815K |
|
36
CDW
CDW
$21.4B
| $4.69M | 1.13% |
18,349
-775
| -4% | -$198K |
|
37
Union Pacific
UNP
$132B
| $3.94M | 0.95% |
16,023
-435
| -3% | -$107K |
|
38
Walmart
WMT
$793B
| $3.6M | 0.87% |
59,850
| – | – |
|
39
Visa
V
$681B
| $3.12M | 0.75% |
11,179
-239
| -2% | -$66.7K |
|
40
Sony
SONY
$162B
| $3.07M | 0.74% |
178,885
-3,140
| -2% | -$53.8K |
|
41
Expedia Group
EXPE
$26.3B
| $3.03M | 0.73% |
21,983
-540
| -2% | -$74.4K |
|
42
Novartis
NVS
$248B
| $2.41M | 0.58% |
24,910
-546
| -2% | -$52.8K |
|
43
AbbVie
ABBV
$374B
| $2.23M | 0.54% |
12,242
| – | – |
|
44
Pfizer
PFE
$141B
| $1.92M | 0.46% |
69,262
-1,262
| -2% | -$35K |
|
|
45
PepsiCo
PEP
$203B
| $1.58M | 0.38% |
9,028
-17,112
| -65% | -$2.99M |
|
46
Sanofi
SNY
$122B
| $1.55M | 0.37% |
31,916
-913
| -3% | -$44.4K |
|
47
Abbott
ABT
$230B
| $1.39M | 0.33% |
12,200
| – | – |
|
48
Unilever
UL
$158B
| $966K | 0.23% |
19,244
-605
| -3% | -$30.4K |
|
49
Kraft Heinz
KHC
$31.9B
| $680K | 0.16% |
18,418
| – | – |
|
50
Procter & Gamble
PG
$370B
| $573K | 0.14% |
3,532
| – | – |
|